SCHEMBL25030248

SCHEMBL25030248

CNCCc1c[nH]c2nccc(O)c12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 5/20 0.60
▸ HTR1A P08908 4/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HTT P42858 1/20 0.45
▸ HTR2C P28335 4/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MTNR1A P48039 2/20 0.44
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNA7 P36544 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ LMNA P02545 3/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39
▸ HTR1D P28221 2/20 0.38
▸ HTR1B P28222 2/20 0.38
▸ HTR2B P41595 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25029889 0.85 HTR2A (0.48) HTR2AHTR1AHTR2CMEN1KMT2A
SCHEMBL24499144 0.81 HTR2A (0.57) HTR2AHTR1AHTR2CHTR1DHTR1B
SCHEMBL25029902 0.79 HTR2A (0.60) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL25030244 0.77 MTNR1A (0.43) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL31742886 0.76 HTR2A (0.65) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL25030251 0.76 HTR2A (0.49) HTR2AHTR1AHTR2CCYP2D6MTNR1A
SCHEMBL29557008 0.75 HTR2A (1.00) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL12352648 0.75 HTR2A (1.00) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL25987650 0.74 HTR2A (0.50) HTR2AHTR1AKDM4EALDH1A1HTT
SCHEMBL25028193 0.73 HTR2A (0.60) HTR2AHTR1AKDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 — — US disclosed
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 — — US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 — — US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 — — US disclosed
WO-2023018864-A1 HALLUCINOGENIC AND NON-HALLUCINOGENIC SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME PSILOSTERICS, LLC (US) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor HTR2C, HTR2A, HTR3C HTR2A 2/4885HTR1A 8/4885KDM4E 1490/4885
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR HTR2C, HTR2A, HTR3B HTR2A 2/4885HTR1A 9/4885KDM4E 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback